Articles from Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Announces Acceptance of Abstracts at the 2026 ASCO Annual Meeting
– Data from Four Studies Spotlight Rising Clinical Interest & Urgency to Address Cisplatin-Induced Hearing Loss and Its Lasting Impact on Patients –
By Fennec Pharmaceuticals Inc. · Via GlobeNewswire · April 21, 2026